Study uncovers a new understanding of how mesenchymal stromal cells benefit patients in cell therapy
The therapeutic benefit to patients receiving mesenchymal stromal cell (MSC) therapy is not because the injected cells remain viable, but because of cell death, researchers at the Monash Biomedicine Discovery Institute (BDI) ...
Nov 11, 2021
0
65